Clinical Research Trials

Key Trial Criteria

• Key Inclusion Criteria

  For a patient to be eligible for participation in this study, all of the following criteria must apply.

  • Histologic or cytologic diagnosis of primary non-small cell Stage 0-II lung cancer,
  • 2- 24 months post-completion of surgery, radiation therapy and/or chemotherapy with no further planned treatment during the 8-week study
  • Score of ≥8 on the anxiety subscale of the HADS1
  • Eastern Cooperative Oncology Group performance status 0-2
  • Hemoglobin ≥9.5
  • Smoking status anticipated to be stable during the study
  • Willing/able to attend brief introductory session and use assigned device for the assigned period of time (15 minutes once or twice per day), 5 days per week for 8 weeks.
  • Age ≥18 years

• Key Exclusion Criteria

  A patient will not be eligible for participation in this study if any of the following criteria apply.

  • Patient does not understand English
  • Active lung infection
  • Radiation pneumonitis currently being treated with oral steroids
  • Unstable angina
  • Pulmonary embolism in past six months
  • Progressive cancer (must be considered no evidence of disease or stable)
  • Active suicidal ideation with plan or intent
  • Any change in psychotropic medications in past month
  • Hearing loss that would preclude participating in interventions.